Department news | December 31, 2022
Debra Morrison, Senior Project Manager and Practice Coach at the AIMS Center is retiring after seven years of work at the AIMS Center and a wonderful career in community health care that spanned over three decades.
Department news | December 31, 2022
A new one-year psychiatry fellowship for advanced nurse practitioners (ARNPs) received a boost with a $6.6 million grant from Premera Blue Cross.
Policygenius | December 30, 2022
Over the last six years, psychedelic drugs have gained increasing acceptance in the medical and legal realms as legitimate treatments for mental health conditions. Nathan Sackett, MD, MS, says researchers are finding growing evidence that psychedelics can help treat conditions like depression, anxiety, and substance abuse.
Department news | December 29, 2022
Pamela Collins, MD, MPH, has accepted a position with the Johns Hopkins Bloomberg School of Public Health as Chair of the Department of Mental Health. This is the only department in the country dedicated to mental health within a School of Public Health.
Department news | December 29, 2022
We are excited to announce that Jacqueline Hobbs, MD, PhD, DFAPA, CMQ, has been selected as the new Program Director for the Psychiatry Residency Training Program after a comprehensive national search!
The Seattle Times | December 24, 2022
Older adults might not realize the toll of loneliness and loss until the negative effects are well entrenched. You can help, especially in this time of year, says Patrick Raue, PhD.
KOMO | December 20, 2022
Holidays can be lonely for seniors. Patricia Areán, PhD, advocates for checking in on a senior who you know is alone.
The Seattle Times | December 18, 2022
Seattle Children’s Ravi Ramasamy, MD, and Lauren Huxtable discuss youth psychiatric boarding as hospitalizations have nearly doubled from 2015 to 2021 amid the youth mental health crisis across Washington state hospitals.
ABC News | December 17, 2022
A national shortage of the drug Adderall has spotlighted a spike in demand for medications that treat the disorder, especially among women. Margaret Sibley, PhD, talks addresses the worry that doctors working through telehealth companies may not have the training to identify misuse.
UW Office of Research | December 16, 2022
Marco Pravetoni, PhD, is featured by the UW Office of Research in their new New Researcher Spotlight series, focused on Neuroscience in January. Dr. Pravetoni’s team has identified promising vaccines against heroin, oxycodone, fentanyl, and their derivatives or combinations.
